Kim Payne to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Kim Payne has written about TOR Serine-Threonine Kinases.
Connection Strength
0.294
-
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021 05; 35(5):1267-1278.
Score: 0.173
-
A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis. Haematologica. 2016 Apr; 101(4):417-26.
Score: 0.121